EMEA-001809-PIP01-15-M01

Key facts

Active substance
  • Imipenem (monohydrate)
  • cilastatin (sodium)
  • relebactam (MK-7655A)
Therapeutic area
Infectious diseases
Decision number
P/0173/2019
PIP number
EMEA-001809-PIP01-15-M01
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Treatment of Gram-negative bacterial infections
Route(s) of administration
Parenteral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Belgium
Tel. +33 180464738
Email: pip.information@merck.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating